143 related articles for article (PubMed ID: 24882847)
1. The TREAT study - trial or tribulation?
Lehman TJ
J Rheumatol; 2014 Jun; 41(6):1038-9. PubMed ID: 24882847
[No Abstract] [Full Text] [Related]
2. Anti-tumour necrosis factor therapy associated with cutaneous vasculitis.
Livermore PA; Murray KJ
Rheumatology (Oxford); 2002 Dec; 41(12):1450-2. PubMed ID: 12468829
[No Abstract] [Full Text] [Related]
3. Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
Nerome Y; Imanaka H; Nonaka Y; Takei S
Mod Rheumatol; 2007; 17(6):526-8. PubMed ID: 18084710
[TBL] [Abstract][Full Text] [Related]
4. Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors.
Wallace CA; Giannini EH; Spalding SJ; Hashkes PJ; O'Neil KM; Zeft AS; Szer IS; Ringold S; Brunner HI; Schanberg LE; Sundel RP; Milojevic DS; Punaro MG; Chira P; Gottlieb BS; Higgins GC; Ilowite NT; Kimura Y; Johnson A; Huang B; Lovell DJ;
J Rheumatol; 2014 Jun; 41(6):1163-70. PubMed ID: 24786928
[TBL] [Abstract][Full Text] [Related]
5. Etanercept improves active polyarticular juvenile rheumatoid arthritis.
Martini A
Clin Exp Rheumatol; 2001; 19(2):122-4. PubMed ID: 11326472
[No Abstract] [Full Text] [Related]
6. Granulomatous disease in a child treated with etanercept.
Alhajri M; Aljumaah S; Aleyouni Y; Al-Qahtani F; Alhazzaa S; Al-Mayouf SM
Int J Rheum Dis; 2013 Aug; 16(4):472-4. PubMed ID: 23826822
[No Abstract] [Full Text] [Related]
7. Response to etanercept in juvenile idiopathic arthritis.
Pang H; Wu XH; Xu JZ
JAMA; 2012 Mar; 307(11):1140; author reply 1140-1. PubMed ID: 22436950
[No Abstract] [Full Text] [Related]
8. Early aggressive therapy for patients with juvenile idiopathic arthritis: are we there yet?
Berard RA; Laxer RM
J Rheumatol; 2014 Dec; 41(12):2343-6. PubMed ID: 25452178
[No Abstract] [Full Text] [Related]
9. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
Wallace CA; Giannini EH; Spalding SJ; Hashkes PJ; O'Neil KM; Zeft AS; Szer IS; Ringold S; Brunner HI; Schanberg LE; Sundel RP; Milojevic D; Punaro MG; Chira P; Gottlieb BS; Higgins GC; Ilowite NT; Kimura Y; Hamilton S; Johnson A; Huang B; Lovell DJ;
Arthritis Rheum; 2012 Jun; 64(6):2012-21. PubMed ID: 22183975
[TBL] [Abstract][Full Text] [Related]
10. Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis.
ten Cate R; van Suijlekom-Smit LW; Brinkman DM; Bekkering WP; Jansen-van Wijngaarden CJ; Vossen JM
Rheumatology (Oxford); 2002 Feb; 41(2):228-9. PubMed ID: 11886975
[No Abstract] [Full Text] [Related]
11. A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study.
Schmeling H; Mathony K; John V; Keysser G; Burdach S; Horneff G
Ann Rheum Dis; 2001 Apr; 60(4):410-2. PubMed ID: 11247875
[TBL] [Abstract][Full Text] [Related]
12. [Application of etanercept in treatment of juvenile idiopathic arthritis and adult onset still disease].
Lewicki M; Kotulska A; Kucharz EJ
Pol Arch Med Wewn; 2005 May; 113(5):505-8. PubMed ID: 16479836
[No Abstract] [Full Text] [Related]
13. Trials reveal promising options for treating juvenile rheumatoid arthritis.
Hampton T
JAMA; 2008 Jan; 299(1):27-8. PubMed ID: 18167400
[No Abstract] [Full Text] [Related]
14. Etanercept improved primary biliary cirrhosis associated with rheumatoid arthritis.
Ogata A; Terabe F; Nakanishi K; Kawai M; Kuwahara Y; Hirano T; Arimitsu J; Hagihara K; Shima Y; Narazaki M; Tanaka T; Kawase I
Joint Bone Spine; 2009 Jan; 76(1):105-7. PubMed ID: 18848488
[No Abstract] [Full Text] [Related]
15. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
Culy CR; Keating GM
Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan.
Mori M; Takei S; Imagawa T; Imanaka H; Nerome Y; Higuchi R; Kawano Y; Yokota S; Sugiyama N; Yuasa H; Fletcher T; Wajdula JS
Mod Rheumatol; 2012 Sep; 22(5):720-6. PubMed ID: 22212889
[TBL] [Abstract][Full Text] [Related]
17. Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial.
ter Wee MM; den Uyl D; Boers M; Kerstens P; Nurmohamed M; van Schaardenburg D; Voskuyl AE; Lems WF
Ann Rheum Dis; 2015 Jun; 74(6):1233-40. PubMed ID: 24818633
[TBL] [Abstract][Full Text] [Related]
18. Etanercept in methotrexate-resistant JIA-related uveitis.
Saeed MU; Raza SH; Goyal S; Cleary G; Newman WD; Chandna A
Semin Ophthalmol; 2014 Jan; 29(1):1-3. PubMed ID: 24175644
[TBL] [Abstract][Full Text] [Related]
19. Etanercept improves rheumatoid arthritis partially responsive to methotrexate.
Cutolo M
Clin Exp Rheumatol; 2001; 19(6):626-7. PubMed ID: 11791631
[No Abstract] [Full Text] [Related]
20. Drug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritis.
Lepore L; Marchetti F; Facchini S; Leone V; Ventura A
Clin Exp Rheumatol; 2003; 21(2):276-7. PubMed ID: 12747299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
